(2008). Modulation of C-reactive protein, tumor necrosis factor-alpha, and adiponectin by diet, exercise, and weight loss.
(2006). Ockene I: Assocation between dietary fiber and serum C-reactive protein.
Oral Glucose Tolerance Test.
(2005). PE: The hyperglycemia-induced inflammatory response in adipocytes: the role of reactive oxygen species.
(2009). Protective role of flax lignans against lead acetate induced oxidative damage and hyperlipidemia in rats. Food Chem Toxicol
(1994). Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-α.
(2004). Serum tumor necrosis factor-α levels and components of the metabolic syndrome in obese adolescents. Metabolism
(2008). Song W: Serum C-reactive protein concentrations are inversely associated with dietary flavonoid intake in U.S.
(2008). Sun S: Dietary flaxseed lignan extract lowers plasma cholesterol and glucose concentrations in hypercholesterolaemic subjects.
(2008). The effect of a lignan complex isolated from flaxseed on inflammation markers in healthy postmenopausal women. Nutr Metab Cardiovasc Dis
(1996). The effect on human tumor necrosis factor alpha and interleukin 1 beta production of diets enriched in n-3 fatty acids from vegetable oil or fish oil.
(2003). Vinicor F: Markers of inflammation and cardiovascular disease. Application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation
(2006). Vitamin E protects the insulin sensitivity and redox balance in rat L6 muscle cells exposed to oxidative stress. Clin Chim Acta
(2005). Wierusz-Wysocka B: Type 2 diabetes mellitus as inflammatory disease. Diabetes Res Clin Pract
(2007). X: Effects of a flaxseed-derived lignan supplement in type 2 diabetic patients: a randomized, double-blind, cross-over trial. PLoS One
(2009). X: Effects of a flaxseed-derived lignan supplement on Creactive protein, IL-6 and retinol-binding protein 4 in type 2 diabetic patients.
(2005). Zampelas A: Apolipoprotein E genotype in dyslipidemic patients and response of blood lipids and inflammatory markers to alpha-linolenic acid. Angiology